David Krempa | Vice President, Business Development |
Sean Brynjelsen | Chief Executive Officer |
Wilson Troutman | Chief Financial Officer |
Paul Stickler | Senior Vice President, Sales and Marketing |
Andrew D’silva | B. Riley Securities |
Ram Selvaraju | H.C. Wainwright |
Good afternoon and welcome to the Eton Pharmaceuticals Fourth Quarter 2020 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company’s request. At this time, I would like to turn it over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals.